Clincosm LogoSign in Get a demo

Prostate Cancer

Showing NaN - NaN of 217
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +2 more
Jul 11, 2022

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

Prostate Cancer Trial in Worldwide (capivasertib, docetaxel, )

Recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +203 more
Jul 27, 2022

Prostate Cancer Trial in United States (Poseidon System)

Completed
  • Prostate Cancer
  • Poseidon System
  • Baltimore, Maryland
  • +4 more
Jul 25, 2022

Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,

Recruiting
  • Advanced Malignant Neoplasm
  • +5 more
  • AMXI-5001:Dose Escalation Phase I
  • AMXI-5001:Dose Expansion Phase II
  • Phoenix, Arizona
  • +7 more
Jul 18, 2022

Prostate Cancer Trial in Canada, United States (Casodex, Eulexin, LHRH agonist)

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +260 more
May 23, 2022

Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )

Completed
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +239 more
May 23, 2022

Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)

Recruiting
  • Prostate Cancer
  • Washington, District of Columbia
  • +3 more
Jun 1, 2022

Prostate Cancer Trial in Baltimore, Detroit (Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams,

Completed
  • Prostate Cancer
  • Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams
  • Physicians: Educational Module
  • Baltimore, Maryland
  • +1 more
May 25, 2022

Prostate Cancer Trial in Baltimore (Radium-223, stereotactic ablative radiotherapy (SABR))

Recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins
May 25, 2022

Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

Recruiting
  • Prostate Cancer
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 6, 2022

Prostate Cancer Trial in Baltimore (Stravix lyopreserved placental tissue (LPT), Radical prostatectomy)

Recruiting
  • Prostate Cancer
  • Stravix lyopreserved placental tissue (LPT)
  • Radical prostatectomy
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 5, 2022

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

Prostate Cancer Trial in Baltimore (18F-DCFPyL Injection)

Active, not recruiting
  • Prostate Cancer
  • 18F-DCFPyL Injection
  • Baltimore, Maryland
    SKCCC
Apr 5, 2022

Prior Negative Prostate Biopsy Setting

Terminated
  • Prostate Cancer
  • ExoDx Prostate
  • Baltimore, Maryland
  • +1 more
Mar 17, 2022

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Prostate Cancer Trial in Baltimore (Hyperpolarized 13C-Pyruvate)

Recruiting
  • Prostate Cancer
  • Hyperpolarized 13C-Pyruvate
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 17, 2022

Prostate Cancer Trial in Baltimore (hypofractionation)

Active, not recruiting
  • Prostate Cancer
  • hypofractionation
  • Baltimore, Maryland
    The Johns Hopkins University School of Medicne
Mar 18, 2022

Prostate Cancer, Castration Resistant Prostate Cancer Trial in United States (Enzalutamide, CC-115)

Active, not recruiting
  • Prostate Cancer
  • Castration Resistant Prostate Cancer
  • San Francisco, California
  • +4 more
Mar 18, 2022

Prostate Cancer Trial in Worldwide (rhPSMA-7.3 (18F) Injection)

Completed
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +33 more
Mar 15, 2022

Prostate Cancer Trial in Finland, Netherlands, United States (rhPSMA-7.3 (18F) Injection)

Completed
  • Prostate Cancer
  • rhPSMA-7.3 (18F) Injection
  • Birmingham, Alabama
  • +27 more
Mar 15, 2022

Prostate Cancer Trial in Canada, Lithuania, United States (No intervention)

Completed
  • Prostate Cancer
  • No intervention
  • Baltimore, Maryland
  • +7 more
Mar 7, 2022

Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer, Cancer of the Prostate Trial in Worldwide (Enzalutamide,

Active, not recruiting
Has Results
  • Nonmetastatic Castration-Resistant Prostate Cancer
  • +2 more
  • Tucson, Arizona
  • +396 more
Feb 22, 2022

Prostate Cancer Trial in United States (ARN-509, Abiraterone, Leuprolide)

Active, not recruiting
  • Prostate Cancer
  • Baltimore, Maryland
  • +10 more
Feb 8, 2022

Prostate Cancer Trial in United States (ARN-509, Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostate Cancer
  • New Orleans, Louisiana
  • +13 more
Feb 5, 2022